MEN1 and pituitary gland adenoma: In line with literature data, our study confirms that in patients with pancreatic NETs, the co-occurrence of other MEN1 manifestations, such as primary hyperparathyroidism and pituitary adenoma, is a strong predictive feature for damaging variants in MEN1 gene.